Literature DB >> 19361849

The outer wall of small airways is a major site of remodeling in fatal asthma.

Marisa Dolhnikoff1, Luiz F F da Silva, Bianca B de Araujo, Higor A P Gomes, Sandra Fernezlian, Adri Mulder, Jan H Lindeman, Thais Mauad.   

Abstract

BACKGROUND: Structural and inflammatory changes in asthma involve both the large and small airways, with involvement of the distal lung being related to disease severity. We have previously shown that changes in the extracellular matrix (ECM) composition of the distal lung are associated with loss of alveolar attachments in patients with fatal asthma. However, major ECM elements, such as collagen I and fibronectin and their regulators, have not been addressed at the distal level.
OBJECTIVE: We sought to evaluate ECM remodeling in the distal lungs of asthmatic patients.
METHODS: Using immunohistochemistry and image analysis, we determined the content of collagen I and III, fibronectin, and matrix metalloproteinases (MMPs) 1, 2, and 9 and tissue inhibitors of metalloproteinase (TIMPs) 1 and 2 in the large and small airways and lung parenchyma of 24 patients with fatal asthma and compared the results with those of 11 nonasthmatic control subjects. Protein content was defined as the area of positive staining divided by basement membrane or septum length.
RESULTS: We observed increased collagen I and decreased collagen III content in the small airways of asthmatic patients compared with that seen in control subjects. Greater fibronectin and MMP-1, MMP-2, and MMP-9 content was observed at the outer area of the small airways in asthmatic patients. MMP content was also increased in the peribronchiolar parenchyma in asthmatic patients. In contrast, TIMP expression was only increased in the large airways of asthmatic patients compared with that seen in control subjects.
CONCLUSIONS: The outer area of the small airways is a major site of ECM remodeling in fatal asthma, potentially contributing to functional changes and the loss of airway-parenchyma interdependence observed in patients with fatal asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361849     DOI: 10.1016/j.jaci.2009.02.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  29 in total

1.  Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases.

Authors:  Gang Liu; Marion A Cooley; Andrew G Jarnicki; Alan C-Y Hsu; Prema M Nair; Tatt Jhong Haw; Michael Fricker; Shaan L Gellatly; Richard Y Kim; Mark D Inman; Gavin Tjin; Peter A B Wark; Marjorie M Walker; Jay C Horvat; Brian G Oliver; W Scott Argraves; Darryl A Knight; Janette K Burgess; Philip M Hansbro
Journal:  JCI Insight       Date:  2016-06-16

2.  Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models.

Authors:  Guoping Li; John Fox; Zhigang Liu; Jun Liu; George F Gao; Yang Jin; Hongwei Gao; Min Wu
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

3.  Development and characterization of a 3D multicell microtissue culture model of airway smooth muscle.

Authors:  Adrian R West; Nishat Zaman; Darren J Cole; Matthew J Walker; Wesley R Legant; Thomas Boudou; Christopher S Chen; John T Favreau; Glenn R Gaudette; Elizabeth A Cowley; Geoffrey N Maksym
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-11-02       Impact factor: 5.464

4.  Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma.

Authors:  D S Ferreira; R Annoni; L F F Silva; M Buttignol; A B G Santos; M C R Medeiros; L N S Andrade; C Y Yick; P J Sterk; J L M Sampaio; M Dolhnikoff; S E Wenzel; T Mauad
Journal:  Clin Exp Allergy       Date:  2012-10       Impact factor: 5.018

Review 5.  Aligning mouse models of asthma to human endotypes of disease.

Authors:  Rebecca A Martin; Samantha R Hodgkins; Anne E Dixon; Matthew E Poynter
Journal:  Respirology       Date:  2014-05-09       Impact factor: 6.424

6.  Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13.

Authors:  Jae Youn Cho; Dae Jae Song; Alexa Pham; Peter Rosenthal; Marina Miller; Shanna Dayan; Taylor A Doherty; Ajit Varki; David H Broide
Journal:  Respir Res       Date:  2010-11-01

7.  Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness?

Authors:  Rakesh K Kumar; Paul S Foster
Journal:  Front Physiol       Date:  2012-07-31       Impact factor: 4.566

8.  Anacardic acids from cashew nuts ameliorate lung damage induced by exposure to diesel exhaust particles in mice.

Authors:  Ana Laura Nicoletti Carvalho; Raquel Annoni; Larissa Helena Lobo Torres; Ana Carolina Cardoso Santos Durão; Ana Lucia Borges Shimada; Francine Maria Almeida; Cristina Bichels Hebeda; Fernanda Degobbi Tenorio Quirino Santos Lopes; Marisa Dolhnikoff; Milton Arruda Martins; Luiz Fernando Ferraz Silva; Sandra Helena Poliselli Farsky; Paulo Hilário Nascimento Saldiva; Cornelia M Ulrich; Robert W Owen; Tania Marcourakis; Maria Teresa Salles Trevisan; Thais Mauad
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-27       Impact factor: 2.629

9.  Extrafine inhaled corticosteroid therapy in the control of asthma.

Authors:  István Ivancsó; Renáta Böcskei; Veronika Müller; Lilla Tamási
Journal:  J Asthma Allergy       Date:  2013-06-06

10.  Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations.

Authors:  Nicola Scichilone; Mario Spatafora; Salvatore Battaglia; Rita Arrigo; Alida Benfante; Vincenzo Bellia
Journal:  J Asthma Allergy       Date:  2013-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.